Browse by Title

Type here to filter the list

W
We Just Started a New Treatment: When, What, and How for Disease Activity Monitoring

Jana G. Al Hashash, MD, MSc, FACG – Mayo Clinic ### 1520160###Bonus Session Speaker###Associate Professor###Mayo Clinic###
Bonus Session Speaker: Jana G. Al Hashash, MD, MSc, FACG – Mayo Clinic
###
Week 48 Efficacy Of Guselkumab And Ustekinumab In Crohn’s Disease Based On Prior Response/Exposure To Biologic Therapy: Results From The GALAXI 2 and 3 Phase 3 Studies (73)

David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine ### 29###Presenting Author###Joseph B. Kirsner Professor of Medicine; Professor of Pathology; Chief, Section of Gastroenterology, Hepatology and Nutrition###University of Chicago Medicine###
Presenting Author: David T. Rubin, MD, FACG (he/him/his) – University of Chicago Medicine
### he/him/his 73
Welcome and Announcements

Jodie A. Barkin, MD, FACG – University of Miami Miller School of Medicine ### 25881###Course Director###Associate Professor of Clinical Medicine###University of Miami Miller School of Medicine###
Course Director: Jodie A. Barkin, MD, FACG – University of Miami Miller School of Medicine
### @@@ Jill K. J. Gaidos, MD, FACG (she/her/hers) – Yale University ### 1732410###Course Director###Associate Professor of Medicine###Yale University###
Course Director: Jill K. J. Gaidos, MD, FACG (she/her/hers) – Yale University
### she/her/hers
Welcome and Course Overview

Brennan Spiegel, MD, MSHS, FACG (he/him/his) – Cedars-Sinai ### 177###Course Director###Professor of Medicine and Public Health, Director of Health Services Research, Cedars-Sinai Health System; Cedars-Sinai Site Director, Clinical and Translational Science Institute (CTSI); Assistant Dean, David Geffen School of Medicine at UCLA###Cedars-Sinai###
Course Director: Brennan Spiegel, MD, MSHS, FACG (he/him/his) – Cedars-Sinai
### he/him/his @@@ Hetal A. Karsan, MD, FACG (he/him/his) – United Digestive ### 1734698###Course Director###Chair of Medical Education###United Digestive###
Course Director: Hetal A. Karsan, MD, FACG (he/him/his) – United Digestive
### he/him/his
Welcome and Introductions

Michelle L. Hughes, MD (she/her/hers) – Yale School of Medicine ### 2201182###Course Director###Assistant Professor###Yale School of Medicine###
Course Director: Michelle L. Hughes, MD (she/her/hers) – Yale School of Medicine
### she/her/hers @@@ Andy Tau, MD (he/him/his) – Austin Gastroenterology ### 2277353###Course Director###Partner###Austin Gastroenterology###
Course Director: Andy Tau, MD (he/him/his) – Austin Gastroenterology
### he/him/his
Welcome and Introductions

Calley H. Levine, MD (she/her/hers) – NewYork-Presbyterian Hospital/Weill Cornell Medical Center ### 2432400###Course Director###Assistant Professor of Medicine###NewYork-Presbyterian Hospital/Weill Cornell Medical Center###
Course Director: Calley H. Levine, MD (she/her/hers) – NewYork-Presbyterian Hospital/Weill Cornell Medical Center
### she/her/hers @@@ Jennifer Katz, MD, FACG – NYU Langone ### 170259###Course Director###Assistant Professor ###NYU Langone###
Course Director: Jennifer Katz, MD, FACG – NYU Langone
###
Welcome and Introductions

Jodie A. Barkin, MD, FACG – University of Miami Miller School of Medicine ### 25881###Course Director###Associate Professor of Clinical Medicine###University of Miami Miller School of Medicine###
Course Director: Jodie A. Barkin, MD, FACG – University of Miami Miller School of Medicine
### @@@ Jill K. J. Gaidos, MD, FACG (she/her/hers) – Yale University ### 1732410###Course Director###Associate Professor of Medicine###Yale University###
Course Director: Jill K. J. Gaidos, MD, FACG (she/her/hers) – Yale University
### she/her/hers
Welcome and Introductions

Brooks D. Cash, MD, FACG (he/him/his) – Baylor University Medical Center/ Baylor Scott and White Dallas ### 135###Course Director###Professor of Medicine; Director of the Functional Bowel Center###Baylor University Medical Center/ Baylor Scott and White Dallas###
Course Director: Brooks D. Cash, MD, FACG (he/him/his) – Baylor University Medical Center/ Baylor Scott and White Dallas
### he/him/his @@@ William D. Chey, MD, FACG – University of Michigan ### 300741###Course Director###H. Marvin Pollard Professor of Gastroenterology; Chief, Division of GI & Hepatology###University of Michigan###
Course Director: William D. Chey, MD, FACG – University of Michigan
###
Welcome and Introductions

Olga A. Aroniadis, MD, MSc, FACG (she/her/hers) – Stony Brook University Hospital ### 1042980###Course Director###Associate Professor of Clinical Medicine###Stony Brook University Hospital###
Course Director: Olga A. Aroniadis, MD, MSc, FACG (she/her/hers) – Stony Brook University Hospital
### she/her/hers @@@ Phillip K. Henderson, DO – University of South Alabama ### 169717###Course Director###Associate Professor of Medicine and Surgery, Medical Director of Liver Transplantation###University of South Alabama ###
Course Director: Phillip K. Henderson, DO – University of South Alabama
###
What Can a Director of Joy and Wellness Do for Providers?

Jonathan A. Leighton, MD, FACG – Mayo Clinic ### 44###Bonus Session Speaker###Professor of Medicine###Mayo Clinic###
Bonus Session Speaker: Jonathan A. Leighton, MD, FACG – Mayo Clinic
###
What's New in Alcohol-Associated Liver Disease?

Loretta L. Jophlin, MD, PhD (she/her/hers) – University of Louisville School of Medicine ### 1734832###Speaker######University of Louisville School of Medicine###
Speaker: Loretta L. Jophlin, MD, PhD (she/her/hers) – University of Louisville School of Medicine
### she/her/hers
When and What to Test for Diarrhea: Focus on Stool Testing

Michael Camilleri, MD, DSc, MACG (he/him/his) – Mayo Clinic College of Medicine and Science ### 80430###Bonus Session Speaker###Professor of Medicine, Pharmacology, and Physiology###Mayo Clinic College of Medicine and Science###
Bonus Session Speaker: Michael Camilleri, MD, DSc, MACG (he/him/his) – Mayo Clinic College of Medicine and Science
### he/him/his
When Do We Stop the Treatment? Recognizing and Managing Adverse Effects Associated With Advanced Therapies

Gary R. Lichtenstein, MD, FACG (he/him/his) – Perelman School of Medicine at the University of Pennsylvania ### 24###Bonus Session Speaker###Professor of Medicine###Perelman School of Medicine at the University of Pennsylvania###
Bonus Session Speaker: Gary R. Lichtenstein, MD, FACG (he/him/his) – Perelman School of Medicine at the University of Pennsylvania
### he/him/his
When Immunotherapy Goes Wrong: Management of Gastrointestinal, Pancreatic, and Hepatic Toxicities

Shilpa Grover, MD, MPH – Brigham & Women's Hospital ### 1055643###Speaker###Director, Onco-Gastroenterology Program###Brigham & Women's Hospital###
Speaker: Shilpa Grover, MD, MPH – Brigham & Women's Hospital
###